CIDP can only be reliably differentiated from clinical mimics through systematic diagnostics. Diagnostic findings guide the selection of suitable immunotherapy. Chronic inflammatory demyelinating polyneuropathy shows diverse phenotypes and is often misdiagnosed. This article summarizes the guideline-compliant diagnostic procedure, explains the role of electrophysiology and shows how variants and antibody profiles determine the choice of immunotherapy.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- From symptom to diagnosis
Gynecomastia and Adipomastia
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management
Trend towards early combination therapy and new strategies for lowering Lp(a)
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment